Brief: Somnomed Says Technology Development Expenditure Is Expected To Decline Over FY24

SomnoMed

24/11/2023 05:59

Nov 24 (Reuters) - Somnomed Ltd  SOM.AX :
    * TECHNOLOGY DEVELOPMENT EXPENDITURE IS EXPECTED TO DECLINE
OVER
FY24
    * CONFIDENT IN ABILITY TO DELIVER  PROVIDED GUIDANCE OF
REVENUE
GROWTH OF AT LEAST 12% AND EBITDA OF AT LEAST A$3 MILLION IN
FY24
    * REMAINS OPTIMISTIC ABOUT ITS CORE TRADING ACTIVITY LEVELS
AND
OUTLOOK FOR COMMERCIALISATION OF REST ASSURE IN FY24
    * FY24 CAPEX INVESTMENT GUIDANCE OF A$5 MILLION

Source text for Eikon:  ID:nASXbRfTw 
Further company coverage:  SOM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))